FDA
-
-
-
-
-
-
-
Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026
-
-
-
-
-
-
-
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Pulmonx Reports Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
D. Boral Capital Starts Pulmonx Corp. (LUNG) at Buy
-
-
-
-
-
-
-
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
-
-
-
-
-
-
Pulmonx Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
-
328,148 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

